-
1
-
-
0026585927
-
Combination chemotherapy vs melphalan and prednisone in the treatment of multiple myeloma: An overview of published trials
-
Gregory WM, Richards MA, Mulpas JS. Combination chemotherapy vs melphalan and prednisone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol 1992; 10: 334-342.
-
(1992)
J Clin Oncol
, vol.10
, pp. 334-342
-
-
Gregory, W.M.1
Richards, M.A.2
Mulpas, J.S.3
-
2
-
-
8944220233
-
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
-
Altal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. New Engl J Med 1996; 335: 91-97.
-
(1996)
New Engl J Med
, vol.335
, pp. 91-97
-
-
Altal, M.1
Harousseau, J.L.2
Stoppa, A.M.3
-
4
-
-
0026532837
-
Syngeneic marrow transplantation in multiple myeloma
-
Topolsky D, Crilley P, Leasure N et al. Syngeneic marrow transplantation in multiple myeloma. Leukemia Res 1992; 16: 415-416.
-
(1992)
Leukemia Res
, vol.16
, pp. 415-416
-
-
Topolsky, D.1
Crilley, P.2
Leasure, N.3
-
5
-
-
0023618813
-
High-dose chemoradiotherapy with syngeneic bone marrow transplantation for multiple myeloma: A case report and literature review
-
Wolff SN, McCurley TL, Giannone L. High-dose chemoradiotherapy with syngeneic bone marrow transplantation for multiple myeloma: a case report and literature review. Am J Hematol 1987; 26: 191-198.
-
(1987)
Am J Hematol
, vol.26
, pp. 191-198
-
-
Wolff, S.N.1
McCurley, T.L.2
Giannone, L.3
-
6
-
-
0029834790
-
Syngeneic marrow transplantation in patients with multiple myeloma
-
Bensinger WI, Demirer T, Buckner CD et al. Syngeneic marrow transplantation in patients with multiple myeloma. Bone Marrow Transplant 1996; 18: 527-531.
-
(1996)
Bone Marrow Transplant
, vol.18
, pp. 527-531
-
-
Bensinger, W.I.1
Demirer, T.2
Buckner, C.D.3
-
7
-
-
0026601366
-
Extramedullary plasmacytoma: Clinical behaviour and response to treatment
-
Soeson M, Paccagnella A, Chiarion-Sileni V et al. Extramedullary plasmacytoma: clinical behaviour and response to treatment. Ann Oncol 1992; 3: 51-57.
-
(1992)
Ann Oncol
, vol.3
, pp. 51-57
-
-
Soeson, M.1
Paccagnella, A.2
Chiarion-Sileni, V.3
-
8
-
-
0027284339
-
High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma
-
Moreau P, Bataille R, Mahé B et al. High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma. J Clin Oncol 1993; 11: 1832.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1832
-
-
Moreau, P.1
Bataille, R.2
Mahé, B.3
-
9
-
-
0026517747
-
High-risk multiple myeloma treated with high-dose melphalan
-
Lokhorst HM, Meuwissen OJ, Verdonck LF et al. High-risk multiple myeloma treated with high-dose melphalan. J Clin Oncol 1992; 10: 47-51.
-
(1992)
J Clin Oncol
, vol.10
, pp. 47-51
-
-
Lokhorst, H.M.1
Meuwissen, O.J.2
Verdonck, L.F.3
-
10
-
-
0026781759
-
Extramedullary progression of multiple myeloma following GM-CSF treatment
-
Celsing F, Hast R, Stenke L et al. Extramedullary progression of multiple myeloma following GM-CSF treatment. Eur J Haematol 1992; 49: 108.
-
(1992)
Eur J Haematol
, vol.49
, pp. 108
-
-
Celsing, F.1
Hast, R.2
Stenke, L.3
-
11
-
-
0029098730
-
Homing mechanisms in the etiopathogenesis of multiple myeloma
-
Van Riet I, Bakkus M, De Greef C et al. Homing mechanisms in the etiopathogenesis of multiple myeloma. Stem Cells 1995; 13 (Suppl. 2): 22-27.
-
(1995)
Stem Cells
, vol.13
, Issue.SUPPL. 2
, pp. 22-27
-
-
Van Riet, I.1
Bakkus, M.2
De Greef, C.3
|